Login / Signup
Momelotinib for myelofibrosis: our 14 years of experience with 100 clinical trial patients and recent FDA approval.
Ayalew Tefferi
Animesh Pardanani
Published in:
Blood cancer journal (2024)
Keyphrases
</>
clinical trial
end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
randomized controlled trial
study protocol
open label
patient reported outcomes
phase ii
patient reported